Bolt Biotherapeutics, Inc.
Nasdaq BOLT · Redwood City, CA
Works in Dermatology · GI & liver · Metabolic & endocrine · Oncology · Renal & urogenital · Respiratory · Women's health
Bolt Biotherapeutics, Inc. is a clinical trial sponsor based in Redwood City, CA, listed as Nasdaq BOLT. It has 1 active clinical trial with 122 planned participants, across 7 therapeutic areas. Since 2021 it has completed 0 trials and stopped 3 early.
Trial track record · since 2021
Financials · Nasdaq BOLT
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Bolt Biotherapeutics, Inc
Bolt Biotherapeutics, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 122 planned participants, in Dermatology, GI & liver, Metabolic & endocrine, Oncology and other areas. Since 2021 it has completed 0 trials and stopped 3 early.
Bolt Biotherapeutics, Inc is based in Redwood City, CA and is listed as Nasdaq BOLT. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Bolt Biotherapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-01-27.
Approve Suite is not affiliated with Bolt Biotherapeutics, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.